Precision Biosciences officer proposes $8.96K sale

The notice also reports 7,056 shares sold during the preceding three months, with an aggregate value of $72,411.93.

Available on EDGAR 11/06/2026 - 04:31 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Precision Biosciences, Inc. (DTIL) officer James Jefferson Smith reported a proposed sale of 875 common shares, with an aggregate market value of $8,955.85, through Fidelity Brokerage Services LLC. The notice lists November 6, 2026, as the sale date. It also reports that James J. Smith sold 7,056 common shares for $72,411.93 during the preceding three months; the remarks identify James J. Smith and J. Jefferson Smith as the same person.

Key Figures

Proposed shares for sale: 875 shares Aggregate market value: $8,955.85 Shares sold: 7,056 shares +1 more

4 metrics

Proposed shares for sale 875 shares James Jefferson Smith; sale date listed as November 6, 2026

Aggregate market value $8,955.85 Proposed sale

Shares sold 7,056 shares James J. Smith, during the preceding three months

Aggregate market value $72,411.93 Shares sold during the preceding three months

Key Terms

Rule 144, Founders Shares, aggregate market value

3 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Founders Shares financial

"Founders Shares"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DTIL shares did James Jefferson Smith propose to sell?

James Jefferson Smith reported a proposed sale of 875 common shares, with an aggregate market value of $8,955.85. The notice lists November 6, 2026, as the sale date and Fidelity Brokerage Services LLC as the broker.

How many DTIL shares did James Jefferson Smith sell in the prior three months?

The notice lists James J. Smith as having sold 7,056 common shares for $72,411.93 during the preceding three months. Its remarks identify James J. Smith and J. Jefferson Smith as the same person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001770169
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PRECISION BIOSCIENCES INC
SEC File Number	001-38841
Address of Issuer	302 EAST PETTIGREW STREET SUITE A-100 DURHAM NORTH CAROLINA 27701
Phone	919-314-5512
Name of Person for Whose Account the Securities are To Be Sold	SMITH J. JEFFERSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	875	8955.85	27935719	11/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/26/2006	Founders Shares	Issuer			875	01/26/2006	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James J. Smith 302 East Pettigrew St. Suite A-100 Durham NC 27701	Common	11/05/2026	7056	72411.93

144: Remarks and Signature

Remarks	James J. Smith and J. Jefferson Smith are one and the same person.
Date of Notice	11/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James Jefferson Smith
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)